Sophia Antipolis, France

Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that it has amended its bond financing agreement with Kreos Capital and drawn down an additional €4 million of debt under the bond financing. Nicox may now draw down a further €3 million or €8 million on December 31, 2019, subject to notice to Kreos by December 16, 2019.

As of June 30, 2019, the Nicox Group had financial debt of €7.4 million under the bond financing agreement with Kreos Capital signed in January 2019. Nicox drew down €8.0 million in January 2019.

Apart from the amended notice dates, payment dates and amounts announced here, all other contractual terms remain unchanged. Full details of the bond agreement can be found in the Press Release of January 25th, 2019 – http://www.nicox.com/assets/files/EN-_Kreos-PR_201901.pdf.